Skip to main content
Top

Indian Journal of Hematology and Blood Transfusion

Issue 3/2011

Content (13 Articles)

Original Article

Evaluation of Platelets as Predictive Parameters in Dengue Fever

K. Jayashree, G. C. Manasa, P. Pallavi, G. V. Manjunath

Original Article

Piperacillin–Tazobactum Plus Amikacin Versus Ceftazidime Plus Amikacin as Empirical Therapy for Fever in Neutropenic Patients with Hematological Malignancies

P. S. Ghalaut, Uma Chaudhary, Veena S. Ghalaut, Atul Dhingra, Gaurav Dixit, Sameer Aggarwal

Original Article

The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms

Jew Win Kuan, Kian Meng Chang, Ngee Siang Lau, Purushothaman Visalachy, Sen Mui Tan, Tee Chuan Ong, Anselm Ting Su

Original Article

Hematopoietic Stem Cell Transplantation in a Very High Risk Group of Patients with the Support of Granulocyte Transfusion

İdil Yenicesu, Gülsan Sucak, Günter Dilsiz, Şahika Zeynep Akı, Zeynep Arzu Yeğin

Original Article

Extra-Venous Use of Autologous Platelet Concentrate: Beginning of a New Era of Therapy of Transfusion Medicine?

Ajit P. Chitre, Varsha Pancholi, Shridhar Archik, Hemant Agrawal

Short Communication

High Frequency of Inherited Variants in the MEFV Gene in Acute Lymphocytic Leukemia

Ozkan Sayan, Emrah Kilicaslan, Serkan Celik, Fatih Tangi, Alev A. Erikci, Osman Ipcioglu, Yavuz S. Sanisoglu, Selim Nalbant, Cagatay Oktenli

Case Report

Unusual Presentation of HIV Vasculopathy in a Child

Deenadayalan Munirathnam, Revathi Raj

Case Report

Transient Leukemia in Down Syndrome: Report of Two Cases with Review of Literature

Alka V. Gosavi, Prashant S. Murarkar, Dhaneshwar N. Lanjewar, Ravishankar V. Ravikar

Case Report

Factor XIII Deficiency in Siblings: Importance of Prophylactic Replacement

Kiran Kini, Deepti Chopra, Pushpa G. Kini

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine